Help us: Donate
Follow us on:
×

Menu

Back

Tag: Sarcopenia

Bold logo
February 26, 2021
Thanks to an injection of seed round cash, a new company, Bold, joins the growing pool of organizations that are focused on wellness and disease prevention. The rising interest in wellness and healthy aging It’s no secret that the interest in digital health and wellness has risen in recent years along with the popularity of...
Elderly resistance training
October 29, 2020
A new study published in Aging has shown that although taking metformin while undergoing resistance training limits muscle growth, it promotes youthful gene expression. The downside As the researchers of this study point out, previous research shows that taking metformin while undergoing physical resistance training (PRT) restricts the development of hypertrophy [1]. While hypertrophy is...
Image of someone editing DNA
August 27, 2020
A gene therapy treatment can ameliorate the loss of motor function and muscle strength in old mice, offering elderly people hope for continuing their active lives. DOK7 is crucial for muscle function Declining motor function is common with aging and can significantly reduce the quality of life. This decline occurs at least in part due...
Interview with Hanadie Yousef
February 10, 2020
At the recent Longevity Therapeutics Conference in San Francisco, we had the chance to interview Hanadie Yousef, the co-founder and CEO of Juvena Therapeutics. Juvena is isolating proteins from embryonic stem cells that promote tissue regrowth. Can you describe in more detail Juvena's approach to developing protein therapeutics that promote tissue regeneration in the elderly?...
Three buildings
January 09, 2020
There are lots of exciting companies working in the aging field, and it's a great time to tell you about three of the more interesting ones. Most of these companies are a while away from human trials yet, but their innovations could possibly be truly game changing. Underdog Pharma Underdog Pharmaceuticals is a spin-off company...
Kevin Strange at EARD2019
October 29, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Kevin Strange discussed his company, Novo Biosciences, and how it is developing small molecules that restore the body's ability to...